Foghorn Therapeutics Inc. (FHTX) vs Nkarta, Inc. (NKTX)
Foghorn Therapeutics Inc. and Nkarta, Inc. are both Biotechnology companies. Foghorn Therapeutics Inc. and Nkarta, Inc. are of similar size ($213.8M and $204.1M). Nkarta, Inc. has the higher net margin (0.00% vs −175.8%) and the lower return on invested capital (−127.2% vs 0.00%). Across the 12 metrics below, Foghorn Therapeutics Inc. leads on 7 and Nkarta, Inc. on 5.
Valuation
Profitability
| Metric | FHTX | NKTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | (198.04%) | 0.00% | 0.00% |
| Net margin | (175.78%) | 0.00% | 0.00% |
| Free cash flow margin | (229.49%) | 0.00% | 0.00% |
| Return on equity | 81.90% | (38.76%) | (57.72%) |
| Return on assets | (30.06%) | (29.86%) | (49.22%) |
| Return on invested capital | 0.00% | (127.22%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack